Phase 2 Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older, of any sex
- People with an activity and health status score (called ECOG) rated 0, 1, or 2, meaning they are able to carry out at least some daily activities, with an expected survival of more than 3 months
- People who have been diagnosed through laboratory testing with high-risk stage II colorectal cancer after surgery (a specific post-surgical cancer stage classification)
- People whose blood test for circulating tumour DNA (ctDNA, tiny fragments of cancer-related DNA in the bloodstream) came back positive about one month after surgery
- People with an expected survival of more than 12 months
- People who are able to understand the study and are willing to sign a consent form agreeing to take part (either personally or through a legally authorised representative or guardian)
Who may not be able to join:
- People who received cancer treatment (such as chemotherapy or radiation) before their surgery
- People who received a blood transfusion during surgery or in the two weeks before surgery
- People who are pregnant or breastfeeding, or people capable of having children who are not using adequate birth control
- People who have had another cancer diagnosed within the past five years, with the exception of certain treated early-stage cervical or non-melanoma skin cancers
- People who have uncontrolled brain tumours or cancer that has spread to the brain or nervous system, or who have significant pressure in the skull or neurological or psychiatric symptoms related to this
- People with serious or uncontrolled ongoing health conditions, including: unstable heart conditions (such as heart attack, heart failure, unstable chest pain, fluid around the heart, or irregular heartbeat) within the six months before joining; diagnosed neurological or psychiatric conditions such as dementia or seizure disorders; severe or uncontrolled infections; a blood-clotting disorder called DIC or a significant tendency to bleed; or major loss of function in important organs
- People who, in the opinion of the medical team running the trial, have any other condition that would make participation unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86-18017312703
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient's 2-year Progression-Free Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.